iScience (Jun 2024)

Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profiles

  • Shan He,
  • Matthew M. Gubin,
  • Hind Rafei,
  • Rafet Basar,
  • Merve Dede,
  • Xianli Jiang,
  • Qingnan Liang,
  • Yukun Tan,
  • Kunhee Kim,
  • Maura L. Gillison,
  • Katayoun Rezvani,
  • Weiyi Peng,
  • Cara Haymaker,
  • Sharia Hernandez,
  • Luisa M. Solis,
  • Vakul Mohanty,
  • Ken Chen

Journal volume & issue
Vol. 27, no. 6
p. 110096

Abstract

Read online

Summary: Recent developments in immunotherapy, including immune checkpoint blockade (ICB) and adoptive cell therapy (ACT), have encountered challenges such as immune-related adverse events and resistance, especially in solid tumors. To advance the field, a deeper understanding of the molecular mechanisms behind treatment responses and resistance is essential. However, the lack of functionally characterized immune-related gene sets has limited data-driven immunological research. To address this gap, we adopted non-negative matrix factorization on 83 human bulk RNA sequencing (RNA-seq) datasets and constructed 28 immune-specific gene sets. After rigorous immunologist-led manual annotations and orthogonal validations across immunological contexts and functional omics data, we demonstrated that these gene sets can be applied to refine pan-cancer immune subtypes, improve ICB response prediction and functionally annotate spatial transcriptomic data. These functional gene sets, informing diverse immune states, will advance our understanding of immunology and cancer research.

Keywords